Tudor Investment Corp’s MaxCyte MXCT Stock Holding History

Tudor Investment Corp’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,512	Closed	-$312K	–	2807
2021 Q3	$312K	Buy	+25,512	New	+$385K	0.01%	2007

Other funds holding MXCT

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RGI

River Global Investors London, United Kingdom $515M AUM 24.86% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Tudor Investment Corp's MXCT Position: Q4 2021 in Review

Tudor Investment Corp sold out of MaxCyte (MXCT) in Q4 2021, closing a stake of 25,512 shares — an estimated $312K sold.

Tudor Investment Corp first reported a position in MXCT in Q3 2021 and held it in 1 quarter. The position peaked at $312K in Q3 2021. 103 funds tracked by Wall St. Rank hold MXCT as of Q4 2021.

Tudor Investment Corp reported no remaining MaxCyte position as of Q4 2021 after selling out during the quarter.
Tudor Investment Corp sold 25,512 MaxCyte shares in Q4 2021, an estimated $312K.
Tudor Investment Corp first reported a position in MaxCyte in Q3 2021 and held it in 1 quarter.
Tudor Investment Corp's MaxCyte position peaked at $312K in Q3 2021.
103 funds tracked by Wall St. Rank held MaxCyte as of Q4 2021.

Based on Tudor Investment Corp's 13F filing for Q4 2021, filed 14 Feb 2022.